The Legal Services Board is an independent regulator that protects consumers and enhances the integrity of legal services in Victoria. The Board aims to:
ensure the effective regulation of the legal profession and the maintenance of professional standards
address the concerns of clients of law practices and legal practitioners through the regulatory system and provide for the protection of consumers of legal services
ensure the adequate management of trust accounts
ensure that the Victorian system is at the forefront of regulation of legal practitioners.
The Grants Program was established in 2007 to distribute funding to projects that aim to improve the administration of laws, increase access to justice, improve legal services and inform and educate the wider community about legal services.
Professor Loane Skene is a Professor of Law in the Faculty of Law and an Adjunct Professor in the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne. She is a member of the Australian Health Ethics Committee, one of the principal Committees of the National Health and Medical Society; and a Deputy Director of the Centre for Law and Human Genetics at the University of Tasmania. She has served on numerous federal and state advisory committees, especially in relation to genetics and the law. In 2005, she was Deputy Chair of the Lockhart Committee on Human Cloning and Embryo Research and became principal spokesperson for the Committee in January 2006. She is the author of books on medical law, and chapters in books and numerous articles in legal, medical and scientific journals. In 2003, she was awarded a Centenary Medal for ‘Service to Australian Society through the Exploration of Legal and Ethical Issues of Health Care’ and in 2007 she was named by the Australian Financial Review among Australia's most powerful cultural figures. http://www.law.unimelb.edu.au/ Contact her on email@example.com http://www.law.unimelb.edu.au/index.cfm?objectid=F9D2D075-B0D0-AB80-E2BC989969E28989&username=Loane%20Skene
The Huntington Study Group (HSG) is a non-profit group of clinical investigators from medical centers in the United States, Canada, Europe, Australia, New Zealand and South America experienced in the care of patients and families affected by Huntington disease and dedicated to clinical research of this hereditary disorder. The HSG focuses on the conception, conduct and communication of clinical research, including treatment trials and observational studies aimed at relieving the burden and slowing the progression of Huntington disease. Please seeClinical Trials and Observational Studies in Progressfor current HSG trials.
Funded by the National Institutes of Health and CHDI Foundation, Inc., PREDICT-HD is an ongoing multinational observational research study of healthy persons who have not been diagnosed with any Huntington disease symptoms but who have tested positive for the HD gene mutation. The study attempts to discover the earliest detectable changes in thinking skills, emotions and brain structure as a person begins the transition from healthy to being diagnosed with HD. Information on these early stages of HD is necessary in order to develop drugs that can slow or postpone the onset of HD. PREDICT-HD researchers hope this study will provide essential information for future trials of experimental drugs for HD.
Information from the I-RESPOND-HD genetic discrimination study was used to create this website. Participants in I-RESPOND-HD were recruited in part from PREDICT-HD.